Investor news

Year 2017

  • 26 may, 2017

    Grifols allocates Euros 218 million to dividends, with a compound annual growth rate of 16% over the last 4 years Download (41.9 Kb)

  • 03 may, 2017

    Bioscience Division sales increase 15% to drive Grifols’ revenue growth by 11% to Euros 1,062 million Download (608.9 Kb)

  • 28 feb, 2017

    Grifols' revenues exceed Euros 4,000 million, driven by +6.5% growth of the Bioscience Division Download (420.8 Kb)

  • 06 feb, 2017

    Grifols refinances debt for USD 6.3 billion, reducing the margin to 200 bps and extending its maturities Download (213.2 Kb)

  • 31 jan, 2017

    Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million Download (164.2 Kb)

Year 2016

  • 14 dec, 2016

    Grifols agreed to acquire Hologic’s share of NAT donor screening unit for USD 1,850 million Download (217.8 Kb)

  • 08 nov, 2016

    Sales of the Bioscience Division grow by +6.5%, increasing Grifols’ revenues to EUR 2,952 million Download (377.6 Kb)

  • 28 jul, 2016

    Sales of the Bioscience Division grow by +7.0%, increasing Grifols’ revenues by +2.7% to EUR 1,952 million Download (141.8 Kb)

  • 27 may, 2016

    Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit Download (222.1 Kb)

  • 05 may, 2016

    Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division Download (256.2 Kb)

  • 08 mar, 2016

    Grifols will invest USD 360M to expand its manufacturing capacities for plasma-derived therapies Download (240.1 Kb)

  • 29 feb, 2016

    Grifols’ revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million Download (347.1 Kb)

  • 26 jan, 2016

    Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the development of therapeutic antibodies against HIV Download (249.7 Kb)

Year 2015

  • 14 dec, 2015

    Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb)

  • 06 nov, 2015

    The intermediate results from the Grifols AMBAR study support its continuation Download (31.1 Kb)

  • 04 nov, 2015

    Grifols’ net profit rises by 18.5% to exceed Euros 400 million, and revenue rises by 17.8% to Euros 2,872 million Download (78.2 Kb)

  • 28 oct, 2015

    Grifols agrees long term loan with the European Investment Bank Download (22.6 Kb)

  • 22 oct, 2015

    Grifols official opening of the Bioscience Division new worldwide operations facility in Ireland Download (48.1 Kb)

  • 30 jul, 2015

    Grifols’ net profit rises by 16.3% to Euros 261.5 million and revenues by 18% exceeding Euros 1,900 million Download (486 Kb)

  • 29 may, 2015

    Grifols allocates €188 million to dividends and maintains payout at 40% of consolidated net profit Download (356.8 Kb)

  • 07 may, 2015

    Grifols’ net profit up by +6.2% to 128.5 million euros and sales grow by 13.8% in the first quarter of 2015 Download (85 Kb)

  • 04 mar, 2015

    Grifols to make a major equity investment in Alkahest Download (380.5 Kb)

  • 26 feb, 2015

    Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014 Download (66.5 Kb)

  • 02 jan, 2015

    Grifols receives FDA approval for its new purification plant to produce Gamunex in Los Angeles Download (232.6 Kb)

Year 2014

  • 04 nov, 2014

    Grifols’ net profit increases by 26.9% to 339 million euros in the nine months to September 2014 Download (93.2 Kb)

  • 19 sep, 2014

    Grifols acquires 50% of the share capital of Kiro Robotics for 21 million euros Download (376.4 Kb)

  • 31 jul, 2014

    Grifols’ net profit rises by 23% to 224.8 million euros in the First Half of 2014 Download (65 Kb)

  • 30 may, 2014

    Grifols sets payout at 40% of consolidated net profit Download (67 Kb)

  • 06 may, 2014

    Grifols’ net profit rises by 32.9% to 121.0 million euros in the First Quarter of 2014 Download (55.3 Kb)

  • 03 apr, 2014

    Grifols opens new plasma fractionation plant in Spain Download (28.8 Kb)

  • 31 mar, 2014

    Japanese Red Cross selects Grifols as partner for nucleic acid screening of nation’s blood supply Download (57.2 Kb)

  • 17 mar, 2014

    Grifols average cost of debt below 3.5% after a reduction of more than 2 points Download (54.5 Kb)

  • 27 feb, 2014

    Grifols’ sales rose by 4.6% to Euros 2,742 million in 2013 Download (110.3 Kb)

Year 2013

  • 17 dec, 2013

    Shareholders endorse Grifols’ Growth strategy Download (47.8 Kb)

  • 11 nov, 2013

    Grifols to acquire a Novartis diagnostics business unit for US$1,675 million Download (31.5 Kb)

  • 05 nov, 2013

    Grifols’ net profit rose by 35.3% to 267 million euros in the nine months period to September 2013 Download (79 Kb)

  • 31 jul, 2013

    Grifols’ net profit rose by 36.9% to 183 million euros in the first half of 2013 Download (68.1 Kb)

  • 15 jul, 2013

    Moody’s upgrades Grifols’ credit ratings with stable outlook Download (40.3 Kb)

  • 24 may, 2013

    Grifols holds its Ordinary General Shareholders’ Meeting Download (119.1 Kb)

  • 15 may, 2013

    Grifols officially inaugurates new immunoglobulin plant in the United States Download (40.1 Kb)

  • 02 may, 2013

    Grifols’ Net Profit Rises by 34.8% to 91 million Euros in the First Quarter of 2013 Download (130.7 Kb)

  • 04 mar, 2013

    Grifols acquires 60% of the capital of biotechnology firm Progenika Biopharma Download (70.3 Kb)

  • 28 feb, 2013

    Grifols’ sales increased by 46% to 2.620 million euros in 2012 Download (67.2 Kb)

Year 2012

  • 04 dec, 2012

    Grifols’ shareholders approve bonus share issue as a remuneration formula Download (64.8 Kb)

  • 31 oct, 2012

    Grifols’ sales increased by 14.4% to 1,959.5 million euros in the first nine months of 2012 Download (63.1 Kb)

  • 19 sep, 2012

    Grifols' Comprehensive Research Strategy in Alzheimer Download (30.3 Kb)

  • 17 sep, 2012

    Grifols agrees to purchase three plasma donation centers in the United States from Canada’s Cangene Download (83.5 Kb)

  • 01 aug, 2012

    Standard & Poor’s Upgrades Grifols’ Credit Rating Download (56.9 Kb)

  • 31 jul, 2012

    Grifols’ sales increase by 15.2% to 1,316.7 million euros in the 1H 2012 Download (153.8 Kb)

  • 09 jul, 2012

    Moody’s upgrades Grifols’ Credit Rating and changes Outlook to Positive Download (59.5 Kb)

  • 24 may, 2012

    Grifols holds its Ordinary General Shareholders’ Meeting Download (91.7 Kb)

  • 24 apr, 2012

    Grifols’ turnover increased by 17.7% to 666.7 million euros in the first quarter of 2012 Download (68.7 Kb)

  • 15 mar, 2012

    Grifols has acquired 51% of the capital of Araclon Biotech to ensure the viability of the purchased company projects Download (96.6 Kb)

  • 28 feb, 2012

    Grifols’ sales increase by 7,7% in constant currency terms in 2011 to 2,300 millon euros Download (195.1 Kb)

Year 2011

  • 07 dec, 2011

    Victor Grifols selected as “Business Leader of the Year 2011” by the Spain - U.S. Chamber of Commerce Download (138.4 Kb)

  • 02 dec, 2011

    Grifols’ shareholders approve bonus share issue as a remuneration formula Download (28.6 Kb)

  • 11 nov, 2011

    Grifols’ sales grow 8% in constant currency terms to 1,712.6 million euros in the 9 months period to September 30, 2011 Download (66.1 Kb)

  • 28 oct, 2011

    Grifols calls Extraordinary General Shareholders’ Meeting Download (46.3 Kb)

  • 28 jul, 2011

    Grifols sales in the first half of 2011 increase 30.2% Download (394.6 Kb)

  • 24 may, 2011

    Grifols holds its General Ordinary Shareholders Meeting Download (69.8 Kb)

  • 05 may, 2011

    Grifols´ sales grow 10.0% to261.4 million Euros in the first quarter of 2011 Download (100.5 Kb)

  • 02 may, 2011

    Grifols and Talecris Biotherapeutics announce the signing of a Consent Agreement with FTC Staff Download (41.7 Kb)

  • 24 feb, 2011

    Grifols' turnover increased by 8.5% in 2010 to 990.7 million euros Download (115.1 Kb)

  • 22 feb, 2011

    Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US Download (46.9 Kb)

  • 18 feb, 2011

    Grifols starts construction of a new plasma fractionation plant in Barcelona Download (26.3 Kb)

  • 25 jan, 2011

    Grifols' shareholders approve the issue of nonvoting shares required to complete the acquisition of Talecris Download (39.5 Kb)

  • 13 jan, 2011

    Grifols closes USD 1.1 billion bond issue(This release will not be distributed in the United States of America, Canada, Australia or Japan) Download (76.7 Kb)

Year 2010

  • 15 sep, 2012

    Grifols expects to close for an amount of USD1.5B the first tranche of the syndicated Financing to acquire Talecris Download (56.9 Kb)

  • 15 dec, 2010

    Grifols obtains EMA license to market its IVIG, Flebogamma® DIF, at 10% concentration Download (47.2 Kb)

  • 24 nov, 2010

    Grifols signs term loan agreements related to Talecris acquisition for USD 3.4 billion Download (54.7 Kb)

  • 23 nov, 2010

    Grifols announces US launch of Flebogamma DIF 10% IVIG Download (252.3 Kb)

  • 04 nov, 2010

    Grifols' turnover increased by 7.1% in the first nine months of 2010 to 738.8MM Euros Download (160.8 Kb)

  • 28 sep, 2010

    Grifols continues investing to boost its Diagnostic division Download (63.9 Kb)

  • 02 sep, 2010

    Grifols obtains FDA license in the US market for its IVIG Flebogamma® DIF 10% concentration Download (56.9 Kb)

  • 29 jul, 2010

    Grifols obtains its first crédit rating from Standard & Poor's and Moody's Download (145.7 Kb)

  • 20 jul, 2010

    Progenika Biopharma grants Grifols World-wide distribution of its Bloodchip® genotyping test for blood donors Download (64 Kb)

  • 24 jun, 2010

    Grifols holds its Annual General Meeting Download (48.5 Kb)

  • 21 jun, 2010

    Grifols holds its Annual General Meeting Download (48.5 Kb)

  • 07 jun, 2010

    Grifols initiates clinical investigation of a new treatment protocol for Alzheimer's disease Download (76.6 Kb)

  • 02 jun, 2010

    Grifols agreement with Pharmalink to acquire the intellectual property for the treatment of Post-Polio Syndrome (PPS) Download (53.7 Kb)

  • 20 may, 2010

    Sales of plasma products have grown by 8.2% at constant currency, reaching 184.6 million euros inthe first quarter of 2010 and driving the group¿s turnover Download (82.9 Kb)

  • 28 apr, 2010

    Sales of plasma products have grown by 8.2% at constant currency, reaching 184.6 million euros inthe first quarter of 2010 and driving the group¿s turnover Download (65 Kb)

  • 25 feb, 2010

    Grifols' net profit increased by 21.6% in 2009 to 148 MM euros Download (190 Kb)

Year 2009

  • 26 may, 2012

    Cerus and Grifols Extend INTERCEPT Blood System Distribution to Italy Download (81 Kb)

  • 23 dec, 2009

    Grifols obtains FDA approval for a new in filling area in its Albumin plant in LA Download (66.6 Kb)

  • 16 dec, 2009

    Grifols and financial institutions unanimously agree the novation of the syndicated facility Download (49 Kb)

  • 09 dec, 2009

    Grifols builds a new solutions factory in Murcia Download (61.3 Kb)

  • 04 nov, 2009

    Grifols reports a 14.9% increase in revenue in the first nine months of 2009 to 689.6 MM euros Download (61.1 Kb)

  • 26 oct, 2009

    Spanish minister of Industry, Tourism and Trade visits Grifols' facilities in LA. Download (42.1 Kb)

  • 16 oct, 2009

    Grifols to break ground on a new testing laboratory in San Marcos, Texas (US). Download (45.5 Kb)

  • 07 oct, 2009

    Grifols completes its USD600 million corporate bond issue in the US Download (44.8 Kb)

  • 21 sep, 2009

    Grifols publishes interim results of its clinical trial on Alzheimer's disease Download (110.6 Kb)

  • 27 jul, 2009

    Grifols' net profit rose 31.4% in the first half of 2009 to 81.7 MM euros Download (140.3 Kb)

  • 30 jun, 2009

    Health Robotics and Grifols sign a collaboration agreement Download (115.3 Kb)

  • 28 may, 2009

    The shares of Grifols will be traded in the United States through ADRs Download (45 Kb)

  • 15 may, 2009

    Grifols holds its Annual General Meeting Download (93.6 Kb)

  • 28 apr, 2009

    Grifols' net profit rose 33.8 % in the first quarter of 2009 to 41.6 million euros Download (127.1 Kb)

  • 03 mar, 2009

    Grifols acquires control over a Swiss and Australian group through a €25 million investment Download (81 Kb)

  • 26 feb, 2009

    Grifols' net profit advanced 38.7% in 2008 to 121.7 million euros. Download (140.9 Kb)

  • 28 jan, 2009

    Grifols Academy of Plasmapheresis opens in US Download (105.7 Kb)

  • 19 jan, 2009

    Health Robotics and Grifols sign a collaboration agreement Download (115.3 Kb)

Year 2008

  • 30 oct, 2008

    Grifols boosts nine-month net profit by 43% to 92.8 million euros Download (132.6 Kb)

  • 14 oct, 2008

    Flebogamma® DIF receives licensing in Australia Download (31.3 Kb)

  • 27 aug, 2008

    Grifols' net profit rose 36.8% in the first half of 2008 to 62.2 million euros Download (128.3 Kb)

  • 29 jul, 2008

    Grifols obtains USD 10.7 million loan to fund the purchase of 4 plasma centres in the United States Download (37.4 Kb)

  • 13 jun, 2008

    Grifols holds its Ordinary General Meeting of Shareholders Download (203.2 Kb)

  • 10 jun, 2008

    Grifols signs an agreement with Gambro Renal Products (GRP) for MARS® in Spain and Portugal Download (82 Kb)

  • 26 may, 2008

    Grifols obtains syndicated financing for 350 million euros Download (116.3 Kb)

  • 14 may, 2008

    Grifols' net profit rose 33% in the first quarter of 2008 to 31.1 million euros Download (69.4 Kb)

  • 07 may, 2008

    Grifols obtains FDA licence for new filling area at its plasma products plant in the USA Download (116.2 Kb)

  • 23 apr, 2008

    Cardinal Health and Grifols concluded an exclusive 6 year distribution agreement Download (34.7 Kb)

  • 15 apr, 2008

    Grifols signs a new distribution agreement with CDEX for Spain, Portugal and Italy Download (54.6 Kb)

  • 12 mar, 2008

    Grifols signs agreement with Stough Development Corporation to open 10 new plasma collection Centers in the United States Download (85.7 Kb)

  • 28 feb, 2008

    Net profits for Grifols increased 93.4% in 2007 to reach 87.8 million euros Download (92.7 Kb)

  • 17 jan, 2008

    Grifols acquires Novartis' former industrial complex 0f 31,000 square meters in Parets del Valles, Barcelona Download (85.3 Kb)

  • 17 jan, 2008

    Grifols’ R&D is qualified as ”Excellent” in the 2007 edition of the Plan Profarma. (spanish version) Download (40.7 Kb)

Year 2007

  • 11 dec, 2007

    The TAC incorporates Grifols into the Ibex-35 Download (27 Kb)

  • 29 oct, 2007

    Grifols to announce Capital Investment Plan for ¿400 million over the next five years Download (107.2 Kb)

  • 22 oct, 2007

    Grifols and Laboratorios Divasa sign a strategic cooperation agreement Download (78.5 Kb)

  • 01 oct, 2007

    Grifols and the Department for Professional, Artistic and Specialized Higher Education sign an agreement to promote higher education in the Vallès Occidental area. Download (61.4 Kb)

  • 29 aug, 2007

    Grifols increases its income by 11.4% to 358 million euros in the first six months of the year Download (127.4 Kb)

  • 23 aug, 2007

    Grifols S.A. and Cerus Corporation agree to commercialize the INTERCEPT Blood System in Spain and Portugal Download (102.8 Kb)

  • 08 jul, 2007

    Grifols increased its business turnover by 8.7% in the first nine months of thr year to 524.5 million euros Download (51.9 Kb)

  • 20 jun, 2007

    Grifols holds its Ordinary General Meeting of Shareholders Download (203.2 Kb)

  • 10 may, 2007

    Grifols' turnover reaches 182 million euros in the first quarter of 2007 Download (246.6 Kb)

  • 04 may, 2007

    Grifols will manage 4 new plasma centers in the United States Download (78 Kb)

  • 18 apr, 2007

    Grifols looks into acquiring Diesse, an Italian company specialized in in vitro diagnostics Download (77.5 Kb)

  • 22 mar, 2007

    Grifols R&D is qualified as excellent in the Profarma Plan 2006 meeting Download (117.3 Kb)

  • 14 mar, 2007

    Grifols announces expansion of US manufacturing capacity Download (94 Kb)

  • 26 feb, 2007

    Grifols reports a 23.8 increase in sales in 2006 Download (125.4 Kb)

Year 2006

  • 27 dec, 2006

    Grifols licensed by the FDA to market a new generation of IGIV in the United States Download (98.5 Kb)

  • 06 nov, 2006

    Grifols reports a 23.7% increase in sales in the first nine months of 2006 Download (96.9 Kb)

  • 12 oct, 2006

    Grifols launches PatientCare Program to address insurance lapses for hemophilia community Download (97.5 Kb)

  • 25 jul, 2006

    Grifols' Diagnostic division launches new in vitro diagnosis line Download (97.5 Kb)

  • 19 jun, 2006

    Grifols signs an agreement with Kardex Remstar for Latin America Download (91.4 Kb)

  • 15 may, 2006

    Grifols sets offer price at €4.4 per share. The offering is 10 times oversubscribed. Download (110.4 Kb)

  • 04 apr, 2006

    Grifols holds its General Shareholders Meeting Download (99 Kb)

  • 02 mar, 2006

    Grifols closes out 2005 with a 15% increase in turnover Download (86.1 Kb)

  • 01 mar, 2006

    Grifols acquires 15 additional plasma collection centers through acquisition of PlasmaCare Download (86.4 Kb)